Structure and function of uridine diphosphate glucuronosyltransferases

被引:202
作者
Meech, R [1 ]
MacKenzie, PI [1 ]
机构
[1] FLINDERS UNIV S AUSTRALIA, DEPT CLIN PHARMACOL, BEDFORD PK, SA 5042, AUSTRALIA
来源
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | 1997年 / 24卷 / 12期
关键词
endoplasmic reticulum residency; functional domains; glucuronidation; topology; uridine diphosphate glucuronosyltransferase;
D O I
10.1111/j.1440-1681.1997.tb02718.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The uridine diphosphate (UDP)-glucuronosyltransferases (UGT) are a family of enzymes that catalyse the covalent addition of glucuronic acid to a nide range of lipophilic chemicals. They play a major role in the detoxification of many exogenous and endogenous compounds by generating products that are more polar and, thus, more readily excreted in bile or urine. 2. Inherited deficiencies in UGT forms are deleterious, as exemplified by the debilitating effects of hyperbilirubinaemia and neurotoxicity in subjects with mutations in the enzyme that converts bilirubin to its more polar glucuronide. 3. The UGT protein can be conceptually divided into two domains with the amino-terminal half of the protein demonstrating greater sequence divergence between isoforms. This region apparently determines aglycone specificity. The aglycone binding site is presumed to be a 'loose' fit, as many structurally diverse substrates can be bound by the same UGT isoform. The carboxyl-terminal half, which is more conserved in sequence between different isoforms, is believed to contain a binding site for the cosubstrate UDP glucuronic acid (UDPGA). 4. Uridine diphosphate glucuronosyltransferase is localized to the endoplasmic reticulum (ER) and spans the membrane with a type I topology. The putative transmembrane domain is located near the carboxyl terminus of the protein such that only a small portion of the protein resides in the cytosol. This cytosolic tail is believed to contain an ER-targeting signal. The major portion of the protein is located in the ER lumen, including the proposed substrate-binding domains and the catalytic site. 5. The microsomal membrane impedes the access of UDPGA to the active site, resulting in latency of UGT activity in intact ER-derived microsomes. Active transport of UDPGA is believed to occur in hepatocytes, but the transport system has not been fully characterized. Uridine diphosphate glucuronosyltransferase activity is also highly lipid dependent and the enzyme may contain regions of membrane association in addition to the transmembrane domain.
引用
收藏
页码:907 / 915
页数:9
相关论文
共 79 条
  • [1] IDENTIFICATION OF DEFECT IN THE GENES FOR BILIRUBIN UDP-GLUCURONOSYL-TRANSFERASE IN A PATIENT WITH CRIGLER-NAJJAR SYNDROME TYPE-II
    AONO, S
    YAMADA, Y
    KEINO, H
    HANADA, N
    NAKAGAWA, T
    SASAOKA, Y
    YAZAWA, T
    SATO, H
    KOIWAI, O
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (03) : 1239 - 1244
  • [2] A NEW-TYPE OF DEFECT IN THE GENE FOR BILIRUBIN URIDINE 5'-DIPHOSPHATE-GLUCURONOSYLTRANSFERASE IN A PATIENT WITH CRIGIER-NAJJAR SYNDROME TYPE-I
    AONO, S
    YAMADA, Y
    KEINO, H
    SASAOKA, Y
    NAKAGAWA, T
    ONISHI, S
    MIMURA, S
    KOIWAI, O
    SATO, H
    [J]. PEDIATRIC RESEARCH, 1994, 35 (06) : 629 - 632
  • [3] LATENCY IS THE MAJOR DETERMINANT OF UDP-GLUCURONOSYLTRANSFERASE ACTIVITY IN ISOLATED HEPATOCYTES
    BANHEGYI, G
    GARZO, T
    FULCERI, R
    BENEDETTI, A
    MANDL, J
    [J]. FEBS LETTERS, 1993, 328 (1-2) : 149 - 152
  • [4] Evidence for an UDP-glucuronic acid phenol glucuronide antiport in rat liver microsomal vesicles
    Banhegyi, G
    Braun, L
    Marcolongo, P
    Csala, M
    Fulceri, R
    Mandl, J
    Benedetti, A
    [J]. BIOCHEMICAL JOURNAL, 1996, 315 : 171 - 176
  • [5] CHEMICAL MODIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE UGT1(ASTERISK)6 BY DIETHYL PYROCARBONATE - POSSIBLE INVOLVEMENT OF A HISTIDINE RESIDUE IN THE CATALYTIC PROCESS
    BATTAGLIA, E
    PRITCHARD, M
    OUZZINE, M
    FOURNELGIGLEUX, S
    RADOMINSKA, A
    SIEST, G
    MAGDALOU, J
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1994, 309 (02) : 266 - 272
  • [6] HEPATIC BILIRUBIN UDP-GLUCURONYL TRANSFERASE ACTIVITY IN LIVER DISEASE AND GILBERTS SYNDROME
    BLACK, M
    BILLING, BH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (23) : 1266 - &
  • [7] BOCK KW, 1994, HDB EXPER PHARM, V112, P391
  • [8] The human gene CGT encoding the UDP-galactose ceramide calactosyl transferase (cerebroside synthase): Cloning, characterization, and assignment to human chromosome 4, band q26
    Bosio, A
    Binczek, E
    LeBeau, MM
    Fernald, AA
    Stoffel, W
    [J]. GENOMICS, 1996, 34 (01) : 69 - 75
  • [9] A MUTATION IN BILIRUBIN URIDINE 5'-DIPHOSPHATE-GLUCURONOSYLTRANSFERASE ISOFORM-1 CAUSING CRIGLER-NAJJAR SYNDROME TYPE-II
    BOSMA, PJ
    GOLDHOORN, B
    ELFERINK, RPJO
    SINAASAPPEL, M
    OOSTRA, BA
    JANSEN, PLM
    [J]. GASTROENTEROLOGY, 1993, 105 (01) : 216 - 220
  • [10] MECHANISMS OF INHERITED DEFICIENCIES OF MULTIPLE UDP-GLUCURONOSYLTRANSFERASE ISOFORMS IN 2 PATIENTS WITH CRIGLER-NAJJAR SYNDROME, TYPE-I
    BOSMA, PJ
    CHOWDHURY, JR
    HUANG, TJ
    LAHIRI, P
    ELFERINK, RPJO
    VANES, HHG
    LEDERSTEIN, M
    WHITINGTON, PF
    JANSEN, PLM
    CHOWDHURY, NR
    [J]. FASEB JOURNAL, 1992, 6 (10) : 2859 - 2863